These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 211004)

  • 1. Clinical implications of growth hormone release inhibiting hormone (GH-RIH).
    Besser GM
    Curr Top Mol Endocrinol; 1976; 3():115-25. PubMed ID: 211004
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide-secreting tumours with special reference to the pancreas.
    Sircus W
    Gut; 1969 Jul; 10(7):506-15. PubMed ID: 4308902
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin: diabetes and acromegaly.
    Gerich JE
    Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870
    [No Abstract]   [Full Text] [Related]  

  • 4. [Somatostatin].
    Tragl KH
    Acta Med Austriaca; 1978; 5(3):80-4. PubMed ID: 377888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Majority and minority cell populations in GEP and bronchial endocrine tumours.
    Sundler F; Alumets J; Håkanson R
    Scand J Gastroenterol Suppl; 1979; 53():9-13. PubMed ID: 225792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin.
    Efendić S; Hökfelt T; Luft R
    Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
    Wilson DM; Hoffman AR
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin (growth hormone-release inhibiting hormone).
    Gomez-Pan A; Hall R
    Clin Endocrinol Metab; 1977 Mar; 6(1):181-200. PubMed ID: 196795
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.
    Murray-Lyon IM; Eddleston AL; Williams R; Brown M; Hogbin BM; Bennett A; Edwards JC; Taylor KW
    Lancet; 1968 Oct; 2(7574):895-8. PubMed ID: 4176152
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion.
    Ferrara JJ; Fucci JC; Benson JB
    Conn Med; 1985 Dec; 49(12):777-80. PubMed ID: 3002718
    [No Abstract]   [Full Text] [Related]  

  • 11. [Somatostatin -- a review (author's transl)].
    Lucke C; Mitzkat HJ; von zur Mühlen A
    Klin Wochenschr; 1976 Apr; 54(7):293-301. PubMed ID: 1263405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic islet cell tumors:insulinoma, gastrinoma, and glucagonoma.
    Higgins GA
    Surg Clin North Am; 1979 Feb; 59(1):131-41. PubMed ID: 220743
    [No Abstract]   [Full Text] [Related]  

  • 13. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor.
    Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell tumors: current concepts and management.
    Schein PS
    Ann Intern Med; 1973 Aug; 79(2):239-57. PubMed ID: 4147411
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
    Ellison EC; O'Dorisio TM; Benson GD
    Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical applications of somatostatin analogs.
    Marbach P; Neufeld M; Pless J
    Adv Exp Med Biol; 1985; 188():339-53. PubMed ID: 2863941
    [No Abstract]   [Full Text] [Related]  

  • 17. [Future therapeutic potentials of somatostatin].
    Rubiés-Prat J
    Med Clin (Barc); 1983 Feb; 80(3):142-3. PubMed ID: 6132031
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
    Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
    Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic islet cell tumor with ACTH, gastrin, and glucagon secretion. Clinical and pathologic studies with multiple therapies.
    Lokich J; Bothe A; O'Hara C; Federman M
    Cancer; 1987 Jun; 59(12):2053-8. PubMed ID: 3032401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary endocrine-secreting pancreatic tumors.
    Macaron C
    Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.